IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
174.49
-4.01 (-2.25%)
At close: Mar 6, 2026, 4:00 PM EST
174.75
+0.26 (0.15%)
After-hours: Mar 6, 2026, 7:34 PM EST
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Technology & Analytics Solutions Revenue | 6.63B | 6.16B | | | | | | | | | |
Technology & Analytics Solutions Revenue Growth | 7.56% | 5.08% | | | | | | | | | |
Research & Development Solutions Revenue | 8.90B | 8.53B | | | | | | | | | |
Research & Development Solutions Revenue Growth | 4.33% | 1.57% | | | | | | | | | |
Contract Sales & Medical Solutions Revenue | 788.00M | 718.00M | | | | | | | | | |
Contract Sales & Medical Solutions Revenue Growth | 9.75% | -1.24% | | | | | | | | | |
| 16.31B | 15.41B | | | | | | | | | |
| 5.88% | 2.81% | | | | | | | | | |
EBIT
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Technology & Analytics Solutions Segment Profit | 1.60B | 1.52B | | | | | | | | | |
Technology & Analytics Solutions Segment Profit Growth | 4.80% | 2.15% | | | | | | | | | |
Research & Development Solutions Segment Profit | 1.87B | 1.95B | | | | | | | | | |
Research & Development Solutions Segment Profit Growth | -3.85% | 1.72% | | | | | | | | | |
Contract Sales & Medical Solutions Segment Profit | 48.00M | 47.00M | | | | | | | | | |
Contract Sales & Medical Solutions Segment Profit Growth | 2.13% | -4.08% | | | | | | | | | |
| -1.33B | -1.32B | | | | | | | | | |
| 2.18B | 2.20B | | | | | | | | | |
Operating Income (Total) Growth | -0.91% | 11.38% | | | | | | | | | |
Key Performance Indicators
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Research & Development Solutions Backlog | 32.70B | 31.10B | | | | | | | | | |
Research & Development Solutions Backlog Growth | 5.15% | 4.71% | | | | | | | | | |
Updated Feb 5, 2026. Data Source:
Fiscal.ai.
